Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proton Therapy in Anal Cancer
NCT03018418Phase 2Active, not recruiting
- Start
- Jan 2017
- Primary completion
- Apr 2022
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in anal cancer. Primary endpoint: Rates of Acute Toxicity at 3 months. Started Jan 2017; status: active, not recruiting.
02
Conditions
anal cancer
Beyond the preview
Go deeper on NCT03018418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03018418.